ID: ALA1808150

Max Phase: Preclinical

Molecular Formula: C31H23NNaO15P

Molecular Weight: 681.50

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(C2Oc3cc(-c4oc5cc(O)cc(O)c5c(=O)c4O)ccc3OC2COP(=O)([O-])Oc2ccc([N+](=O)[O-])cc2)ccc1O.[Na+]

Standard InChI:  InChI=1S/C31H24NO15P.Na/c1-42-23-10-15(2-8-20(23)34)30-26(14-43-48(40,41)47-19-6-4-17(5-7-19)32(38)39)44-22-9-3-16(11-24(22)45-30)31-29(37)28(36)27-21(35)12-18(33)13-25(27)46-31;/h2-13,26,30,33-35,37H,14H2,1H3,(H,40,41);/q;+1/p-1

Standard InChI Key:  UZXLNMDPBKUKRR-UHFFFAOYSA-M

Associated Targets(non-human)

Rat1 211 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 681.50Molecular Weight (Monoisotopic): 681.0884AlogP: 5.28#Rotatable Bonds: 9
Polar Surface Area: 237.72Molecular Species: ACIDHBA: 14HBD: 5
#RO5 Violations: 3HBA (Lipinski): 16HBD (Lipinski): 5#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.36CX Basic pKa: CX LogP: 4.82CX LogD: 1.32
Aromatic Rings: 5Heavy Atoms: 48QED Weighted: 0.08Np Likeness Score: 1.20

References

1. Zarrelli A, Sgambato A, Petito V, De Napoli L, Previtera L, Di Fabio G..  (2011)  New C-23 modified of silybin and 2,3-dehydrosilybin: synthesis and preliminary evaluation of antioxidant properties.,  21  (15): [PMID:21737270] [10.1016/j.bmcl.2011.06.049]

Source